Dr. Robert Zimmerman, MD

NPI: 1265472427
Total Payments
$114.85
2023 Payments
$28.12
Companies
3
Transactions
3
Medicare Patients
5,118
Medicare Billing
$219,567

Payment Breakdown by Category

Food & Beverage$114.85 (100.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $114.85 3 100.0%

Top Paying Companies

Company Total Records Latest Year
AstraZeneca Pharmaceuticals LP $59.03 1 $0 (2019)
Daiichi Sankyo Inc. $28.12 1 $0 (2023)
Roche Diagnostics Corporation $27.70 1 $0 (2019)

Payment History by Year

Year Amount Transactions Top Company
2023 $28.12 1 Daiichi Sankyo Inc. ($28.12)
2019 $86.73 2 AstraZeneca Pharmaceuticals LP ($59.03)

All Payment Transactions

3 individual payment records from CMS Open Payments

Date Company Product Nature Form Amount Type
03/15/2023 Daiichi Sankyo Inc. Enhertu (Drug) Food and Beverage In-kind items and services $28.12 General
Category: ONCOLOGY
10/22/2019 Roche Diagnostics Corporation TD BenchMark IHC/ISH and Special Stains Reagents (Device) Food and Beverage In-kind items and services $27.70 General
Category: Tissue Diagnostics
01/22/2019 AstraZeneca Pharmaceuticals LP IMFINZI (Drug) Food and Beverage In-kind items and services $59.03 General
Category: Cardiovascular and Metabolism

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 14 1,448 2,411 $501,690 $63,757
2022 16 1,555 2,495 $609,273 $69,888
2021 14 991 1,510 $208,562 $37,984
2020 16 1,124 1,745 $244,096 $47,939
Total Patients
5,118
Total Services
8,161
Medicare Billing
$219,567
Procedure Codes
60

All Medicare Procedures & Services

60 procedure records from CMS Medicare Utilization — Page 2 of 3

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
88333 Pathology cytologic examination of specimen during surgery, initial site Facility 2022 11 14 $2,731 $724.17 26.5%
88312 Special stained specimen slides to identify organisms including interpretation and report Facility 2022 19 28 $4,350 $615.70 14.2%
88300 Pathology examination of tissue using a microscope, limited examination Facility 2022 131 149 $10,425 $535.90 5.1%
85097 Bone marrow, smear interpretation Facility 2022 11 11 $1,948 $437.18 22.4%
88313 Special stained specimen slides to examine tissue including interpretation and report Facility 2022 26 40 $4,720 $385.26 8.2%
88305 Pathology examination of tissue using a microscope, intermediate complexity Facility 2021 295 520 $59,753 $16,358 27.4%
88341 Special stained specimen slides to examine tissue, each additional procedure Facility 2021 59 174 $25,305 $4,107 16.2%
88342 Special stained specimen slides to examine tissue, initial procedure Facility 2021 94 117 $33,315 $3,424 10.3%
88307 Pathology examination of tissue using a microscope, moderately high complexity Facility 2021 34 41 $18,542 $2,858 15.4%
88112 Cell examination of specimen, selective cellular enhancement technique Facility 2021 54 76 $15,531 $1,718 11.1%
88173 Evaluation of fine needle aspirate with interpretation and report Facility 2021 25 30 $9,267 $1,678 18.1%
88333 Pathology cytologic examination of specimen during surgery, initial site Facility 2021 22 26 $6,552 $1,323 20.2%
88311 Preparation of tissue for examination by removing any calcium present Facility 2021 109 123 $4,956 $1,290 26.0%
88304 Pathology examination of tissue using a microscope, moderately low complexity Facility 2021 120 133 $6,455 $1,246 19.3%
88313 Special stained specimen slides to examine tissue including interpretation and report Facility 2021 32 108 $9,698 $1,111 11.5%
88312 Special stained specimen slides to identify organisms including interpretation and report Facility 2021 38 46 $6,026 $1,038 17.2%
85097 Bone marrow, smear interpretation Facility 2021 24 24 $5,946 $996.48 16.8%
88104 Cell examination of body fluid, smears Facility 2021 23 25 $3,475 $578.75 16.7%
88300 Pathology examination of tissue using a microscope, limited examination Facility 2021 62 67 $3,741 $258.00 6.9%
88305 Pathology examination of tissue using a microscope, intermediate complexity Facility 2020 374 634 $63,400 $20,152 31.8%
88341 Special stained specimen slides to examine tissue Facility 2020 68 242 $36,680 $5,990 16.3%
88307 Pathology examination of tissue using a microscope, moderately high complexity Facility 2020 56 65 $26,910 $4,508 16.8%
88342 Tissue or cell analysis by immunologic technique Facility 2020 92 102 $28,458 $3,136 11.0%
88312 Special stained specimen slides to identify organisms including interpretation and report Facility 2020 56 70 $9,170 $1,611 17.6%
88173 Evaluation of fine needle aspirate with interpretation and report Facility 2020 21 26 $7,306 $1,557 21.3%

About Dr. Robert Zimmerman, MD

Dr. Robert Zimmerman, MD is a Anatomic Pathology healthcare provider based in Pottstown, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/07/2006. The National Provider Identifier (NPI) number assigned to this provider is 1265472427.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Zimmerman, MD has received a total of $114.85 in payments from pharmaceutical and medical device companies, with $28.12 received in 2023. These payments were reported across 3 transactions from 3 companies. The most common payment nature is "Food and Beverage" ($114.85).

As a Medicare-enrolled provider, Zimmerman has provided services to 5,118 Medicare beneficiaries, totaling 8,161 services with total Medicare billing of $219,567. Data is available for 4 years (2020–2023), covering 60 distinct procedure/service records.

Practice Information

  • Specialty Anatomic Pathology
  • Location Pottstown, PA
  • Active Since 06/07/2006
  • Last Updated 12/01/2016
  • Taxonomy Code 207ZP0101X
  • Entity Type Individual
  • NPI Number 1265472427

Products in Payments

  • IMFINZI (Drug) $59.03
  • Enhertu (Drug) $28.12
  • TD BenchMark IHC/ISH and Special Stains Reagents (Device) $27.70

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.